TribLIVE

| News


 
Larger text Larger text Smaller text Smaller text | Order Photo Reprints

Treatment devised at Pitt could ease breathing woes

About Adam Smeltz

By Adam Smeltz

Published: Sunday, March 31, 2013, 12:59 p.m.

A new molecule developed in Pittsburgh eases inflammation in rodent cases of pneumonia, a discovery that could help people with respiratory infections, according to research released on Sunday.

A refined version of the treatment eventually “might be useful in improving outcomes” for pneumonia patients, said Dr. Rama Mallampalli, a vice chairman for research in the University of Pittsburgh School of Medicine. He said clinical trials for people could materialize within a few years.

The Department of Veterans Affairs and the National Institutes of Health supported the research, conducted during the past three to four years at Pitt and the VA Pittsburgh Healthcare System.

Mallampalli is the senior author in a paper about the findings, published this week in the journal Nature Immunology.

He said researchers are looking at whether other treatments could have a similar effect on ailments such as arthritis, asthma and colitis, all of which involve inflammation.

 

 

 
 


Show commenting policy

Most-Read Allegheny

  1. 1 dead, 1 wounded in shooting at Chartiers party
  2. Patients denied as donor organs discarded
  3. Film tax credits bill would bump up state budget
  4. Bethel Park man to receive degree from Pitt he earned 64 years ago
  5. Castle Shannon man accused of crashing way down Pittsburgh street
  6. Pope Francis inspires incredible optimism
  7. Newsmaker: Linda J. O’Neill
  8. Newsmaker: Rosalind Ross
  9. Obama hopes to replicate CCAC job training efforts across United States
  10. South Fayette parents express dissatisfaction with handling of bullying
  11. Leader guided changes at Robert Morris
Subscribe today! Click here for our subscription offers.